Metabolic characterization of volume overload heart failure due to aorto-caval fistula in rats

Vojtech Melenovsky1, Jan Benes, Petra Skaroupkova

  • 1Department of Cardiology and Center for Cardiovascular Research, Institute for Clinical and Experimental Medicine-IKEM, Videnska 1958/9, Prague 4, 140 21, Czech Republic. vojtech.melenovsky@ikem.cz

Insights

Heart failure (HF) involves metabolic changes in fat and heart tissue. This study in a rat model shows altered fat metabolism and reduced heart triglycerides, suggesting complex interactions in HF progression.

Area of Science:

  • Cardiovascular Metabolism
  • Molecular Cardiology
  • Adipose Tissue Biology

Background:

  • Metabolic crosstalk between adipose tissue and the heart is implicated in heart failure (HF) progression.
  • Understanding these interactions is crucial for developing targeted therapies.

Purpose of the Study:

  • To investigate metabolic and gene expression changes in cardiac and adipose tissues during chronic volume overload-induced HF in rats.
  • To elucidate the role of metabolic dysregulation in the pathophysiology of decompensated HF.

Main Methods:

  • Induction of HF via aorto-caval fistula (ACF) in Wistar rats, studied at the decompensated phase (22nd week).
  • Assessment of cardiac structure, function, systemic glucose/lipid metabolism, and isolated organ function (adipose tissue lipolysis/lipogenesis).
  • Analysis of myocardial gene/protein expression for HF markers, signaling pathways, and metabolic enzymes; adipose tissue transcription profiling.

Main Results:

  • ACF rats exhibited cardiac hypertrophy, pulmonary congestion, and intraabdominal fat depletion.
  • Preserved glucose tolerance but elevated circulating free fatty acids (FFA) and attenuated insulin response were observed.
  • Myocardial triglycerides were reduced, anti-oxidative reserve attenuated, HF markers and specific signaling pathways upregulated, and mitochondrial fatty acid oxidation enzymes downregulated.
  • Adipose tissue showed preserved responsiveness but upregulated gastric inhibitory polypeptide receptor.

Conclusions:

  • The ACF-induced HF model demonstrates significant systemic metabolic derangements.
  • Low myocardial triglycerides and attenuated insulin levels argue against direct lipotoxicity or insulin resistance in this model.
  • Impaired postprandial insulin response and reduced antilipolytic effects may contribute to fat depletion in ACF-HF.

Related Concept Videos